* KORU Medical Systems Inc KRMD.OQ KRMD.O is expected
to show
a rise in quarterly revenue when it reports results on May 4.
* The Mahwah New Jersey-based company is expected to report
a
19.1% increase in revenue to $7.44 million from $6.24 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for KORU Medical
Systems Inc
is for a loss of 5 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for KORU
Medical
Systems Inc is $4.5, above its last closing price of $4.05.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.06 -0.06 -0.04 Beat 29.4
Sep. 30 2022 -0.05 -0.05 -0.03 Beat 43.7
Jun. 30 2022 -0.06 -0.07 -0.07 Met 0
Mar. 31 2022 -0.06 -0.06 -0.06 Met -5.9
Dec. -0.04 -0.03 -0.02 Beat 40
31 2021
Sep. 30 2021 -0.03 -0.02 -0.02 Met 14.3
Jun. 30 2021 -0.02 -0.02 -0.03 Missed -50
Mar. 31 2021 -0.01 -0.01 -0.03 Missed -349.8
This summary was machine generated May 3 at 02:07 GMT. All
figures in US dollars unless otherwise stated